Keyphrases
Apoptosis
100%
Caspase-8
100%
ROS Production
100%
Skin Cancer Cells
100%
Imiquimod-induced
100%
Lysosomal Membrane Permeabilization
100%
Imiquimod
57%
Caspase-8 Activation
57%
Lysosome
28%
Induced Cell Death
28%
Cathepsin
28%
Flow Cytometry
14%
Clinical Treatment
14%
Induced Apoptosis
14%
Cytotoxicity
14%
Cell Death
14%
In Cancer
14%
Cancer Cells
14%
Protein Expression
14%
Antiviral Activity
14%
Melanoma Cells
14%
Antitumor Activity
14%
Immunoblotting
14%
Cancer Cell Lines
14%
Confocal Microscopy
14%
Pharmacological Inhibitors
14%
Mitochondrial Dysfunction and Apoptosis
14%
Human Melanoma Cells
14%
Proteolytic Enzymes
14%
B16F10
14%
Toll-like Receptor 7 (TLR7)
14%
Cell Counting kit-8 (CCK-8)
14%
Content Assay
14%
DNA Content
14%
Lysosomal Adaptation
14%
Lysosome Function
14%
Skin Malignancy
14%
Lysosome Biogenesis
14%
Lysosomal Disease
14%
ROS Scavenger
14%
Human Skin Cancer Cells
14%
ROS Accumulation
14%
Mouse Melanoma Cells
14%
Lysosome Degradation
14%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Caspase 8
100%
Programmed Cell Death
100%
Cell Death
87%
Lysosome
62%
Cathepsin
25%
Confocal Microscopy
12%
Cytotoxicity
12%
Protein Expression
12%
Antineoplastic Activity
12%
Biogenesis
12%
Mitochondrial Disorder
12%
Antiviral Activity
12%
TLR7
12%
DNA Content
12%
Flow Cytometry
12%
Immunoblotting
12%
Peptidase
12%
Immunology and Microbiology
Cancer Cell
100%
Caspase
100%
Imiquimod
100%
Programmed Cell Death
100%
Cell Death
63%
Lysosome
45%
Cytotoxicity
9%
Western Blot
9%
Protein Expression
9%
Cytosol
9%
Antineoplastic Activity
9%
Biogenesis
9%
Melanoma Cell Line
9%
Antiviral Activity
9%
TLR7
9%
DNA Content
9%
Skin Cancer Cell Line
9%
Confocal Microscopy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Skin Cancer
100%
Caspase 8
100%
Imiquimod
100%
Cathepsin
18%
Malignant Neoplasm
9%
Western Blot
9%
Proteinase
9%
Melanoma
9%
Antitumor Activity
9%
Flow Cytometry
9%
Confocal Microscopy
9%
Antiviral Activity
9%
Toll Like Receptor 7
9%
Cytotoxicity
9%